LJPC - La Jolla Pharmaceutical Company

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
19,988
10,056
0
616
Cost of Revenue
2,805
1,643
-
-
Gross Profit
17,183
8,413
-
-
Operating Expenses
Research Development
92,036
117,302
84,575
62,288
Selling General and Administrative
53,268
85,162
30,852
16,700
Total Operating Expenses
145,304
202,464
115,427
78,988
Operating Income or Loss
-128,121
-194,051
-115,427
-78,372
Interest Expense
11,120
7,303
-
-
Total Other Income/Expenses Net
-
-
624
187
Income Before Tax
-136,693
-199,469
-114,803
-78,185
Income Tax Expense
-
-
-
-
Income from Continuing Operations
-136,693
-199,469
-114,803
-78,185
Net Income
-136,693
-199,469
-114,803
-78,185
Net Income available to common shareholders
-136,693
-199,469
-114,803
-78,185
Reported EPS
Basic
-
-7.85
-5.41
-4.54
Diluted
-
-7.85
-5.41
-4.54
Weighted average shares outstanding
Basic
-
25,422
21,215
17,228
Diluted
-
25,422
21,215
17,228
EBITDA
-
-187,761
-114,159
-77,642